INTRODUCTION :

Medical devices are rapidly evolving into intelligent, connected systems that interact with hospital networks, cloud platforms, and remote clinical services. While this digital transformation improves patient care, it also introduces cyber risks that can directly affect safety, accuracy, and availability. Under IEC 60601, manufacturers must now prove that cybersecurity weaknesses do not compromise the basic safety or essential performance of medical electrical equipment.

In Finland’s highly advanced healthcare and digital health ecosystem, cybersecurity assurance is becoming a core expectation during medical device compliance testing. Cyberintelsys delivers specialized medical device security testing and Vulnerability Assessment & Penetration Testing (VA/PT) to support IEC 60601 compliance and cyber risk assessment, using CREST-aligned security methodologies and globally accepted best practices.

Why Cyber Risk Assessment Matters for IEC 60601

IEC 60601 requires manufacturers to demonstrate that foreseeable risks—including those originating from cybersecurity threats—are identified and controlled. Cyber incidents can introduce hazardous situations such as incorrect device behavior, loss of monitoring capability, or delayed clinical response.

Cyber risk assessment ensures that:

• Cyber threats are treated as safety-related hazards

• Device functionality remains reliable under cyber stress

• Essential performance is protected during abnormal conditions

• Compliance evidence is defensible during audits and testing

In Finland, this approach aligns with the country’s strong emphasis on technology reliability and patient safety.

Role of VA/PT in Medical Device Cybersecurity Assurance

Vulnerability Assessment and Penetration Testing provide hands-on, evidence-based validation of a device’s cybersecurity posture. Unlike design reviews alone, VA/PT demonstrates how a device behaves when exposed to real-world attack scenarios.

Key outcomes of VA/PT include:

• Identification of exploitable weaknesses before market release

• Validation of security controls under realistic conditions

• Reduced risk of compliance delays or test failures

• Stronger confidence for regulators, labs, and healthcare providers

For IEC 60601 compliance, VA/PT supports proof that cybersecurity controls do not interfere with essential performance.

Cyberintelsys Medical Device Security Testing Approach

Comprehensive Cyber Exposure Mapping

Cyberintelsys begins by identifying all cyber exposure points, including:

• Network, wired, and wireless interfaces

• Embedded operating systems and firmware

• User access pathways and service ports

• Data exchange with external systems

• Third-party software and dependencies

This creates a complete view of the device’s cyber attack surface.

Targeted Vulnerability Assessment

The vulnerability assessment phase focuses on:

• Secure configuration and system hardening

• Identification of known and emerging vulnerabilities

• Review of authentication, authorization, and session handling

• Evaluation of encryption and data protection mechanisms

Each finding is linked to potential safety and operational impacts.

CREST-Aligned Penetration Testing

Cyberintelsys performs CREST-aligned penetration testing tailored for medical devices, ensuring:

• Controlled testing that avoids disruption to safety functions

• Simulation of realistic attacker techniques

• Assessment of defense-in-depth strategies

• Clear, reproducible results suitable for compliance documentation

Testing is carefully scoped to respect patient safety and regulatory expectations.

Risk Rating and Mitigation Guidance

Identified issues are:

• Rated based on exploitability and impact

• Mapped to IEC 60601 safety considerations

• Prioritized for remediation

• Verified through re-testing where required

Cyberintelsys provides clear guidance to support effective and proportionate risk reduction.

Alignment with IEC, ISO, and Security Best Practices

Cyberintelsys aligns security testing with:

• IEC 60601 – Safety and essential performance requirements

• ISO 14971 – Medical device risk management

• IEC 81001-5-1 – Secure product lifecycle processes

• CREST methodologies – Trusted penetration testing standards

• Secure development and operational security principles

This integrated approach ensures cybersecurity testing directly supports compliance readiness.

Compliance-Ready Reporting for Finland and EU Markets

Cyberintelsys delivers documentation designed for regulatory review, including:

• VA/PT reports tailored for medical device compliance

• Clear traceability between vulnerabilities, risks, and controls

• Residual risk statements

• Inputs for the Risk Management File and technical documentation

These deliverables support IEC 60601 testing, CE marking, and EU market submissions.

Supporting Finland’s High-Trust Healthcare Environment

Finland’s healthcare system places strong emphasis on reliability, resilience, and trust in medical technology. Proactive medical device security testing helps manufacturers:

• Protect patient safety in connected environments

• Reduce post-market cybersecurity risk

• Improve product quality and longevity

• Build confidence with hospitals and regulators

Cybersecurity is increasingly viewed as a measure of medical device maturity.

Why Cyberintelsys

• Dedicated expertise in medical device cybersecurity

• CREST-aligned, regulator-aware testing methodologies

• Strong understanding of IEC 60601 compliance expectations

• Practical, actionable remediation support

• Experience supporting Nordic and EU medical device markets

Cyberintelsys enables manufacturers to convert cybersecurity testing results into compliance confidence.

Conclusion

Medical device security testing and VA/PT are essential for achieving IEC 60601 compliance in today’s connected healthcare landscape. By combining CREST-aligned penetration testing, structured cyber risk assessment, and deep knowledge of medical electrical safety requirements, Cyberintelsys helps manufacturers in Finland demonstrate that their devices are safe, secure, and ready for regulatory approval.

A proactive cybersecurity testing strategy not only supports compliance but also strengthens patient safety, system reliability, and long-term trust in medical technology.